However, the perspective of the regulatory authorities is adapting fast to the real world and patient's needs. The FDA developed in 2016 a new guidance entitled "Technical Considerations for Additive Manufactured Devices" in order to provide the FDA's initial thinking on technical considerations ...
Blocking IL-17 could provide a novel therapeutic strategy for COVID-19 [69]. CSS is an extremely life-threatening situation that can lead to harmful effects, such as loss of capillaries, tissue toxicity, organ failure, and shock. The activation of platelets triggered by this cytokine activation...